Fibrinolytic Agents/administration & dosage/*therapeutic use
Middle Cerebral Artery/pathology
Stroke/*drug therapy/*pathology
Thrombolytic Therapy/*methods
Tissue Plasminogen Activator/administration & dosage/*therapeutic use
Humans
Male
Aged
Female
Middle Aged
Severity of Illness Index
Prospective Studies
Treatment Outcome
Regression Analysis
Age Factors
Predictive Value of Tests
Retrospective Studies
Infusions, Intravenous
*Diffusion Magnetic Resonance Imaging
Fibrinolytic Agents/administration & dosage/*therapeutic use
Middle Cerebral Artery/pathology
Stroke/*drug therapy/*pathology
Thrombolytic Therapy/*methods
Tissue Plasminogen Activator/administration & dosage/*therapeutic use
Beschreibung:
Stroke magnetic resonance imaging with perfusion and diffusion weighting has shown its potential to select patients likely to benefit from intravenous thrombolysis with tissue-type plasminogen activator (IV-tPA). We aimed to determine the predictors of favorable outcome in magnetic resonance imaging-selected, acute stroke patients treated with IV-tPA.
Stroke magnetic resonance imaging with perfusion and diffusion weighting has shown its potential to select patients likely to benefit from intravenous thrombolysis with tissue-type plasminogen activator (IV-tPA). We aimed to determine the predictors of favorable outcome in magnetic resonance imaging-selected, acute stroke patients treated with IV-tPA.